BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23613113)

  • 21. Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome.
    Sana ME; Spitaleri A; Spiliotopoulos D; Pezzoli L; Preda L; Musco G; Ferrazzi P; Iascone M
    Am J Med Genet A; 2014 Aug; 164A(8):2069-73. PubMed ID: 24782337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The recurrent PPP1CB mutation p.Pro49Arg in an additional Noonan-like syndrome individual: Broadening the clinical phenotype.
    Bertola D; Yamamoto G; Buscarilli M; Jorge A; Passos-Bueno MR; Kim C
    Am J Med Genet A; 2017 Mar; 173(3):824-828. PubMed ID: 28211982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.
    Yin JC; Platt MJ; Tian X; Wu X; Backx PH; Simpson JA; Araki T; Neel BG
    Nat Commun; 2017 May; 8():15518. PubMed ID: 28548091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac transplantation in children with Noonan syndrome.
    McCallen LM; Ameduri RK; Denfield SW; Dodd DA; Everitt MD; Johnson JN; Lee TM; Lin AE; Lohr JL; May LJ; Pierpont ME; Stevenson DA; Chatfield KC
    Pediatr Transplant; 2019 Sep; 23(6):e13535. PubMed ID: 31259454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional aspects of Noonan syndrome and Noonan-related disorders.
    da Silva FM; Jorge AA; Malaquias A; da Costa Pereira A; Yamamoto GL; Kim CA; Bertola D
    Am J Med Genet A; 2016 Jun; 170(6):1525-31. PubMed ID: 27038324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
    Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
    Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.
    Malaquias AC; Brasil AS; Pereira AC; Arnhold IJ; Mendonca BB; Bertola DR; Jorge AA
    Am J Med Genet A; 2012 Nov; 158A(11):2700-6. PubMed ID: 22887833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
    Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
    Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAF1 variant in a patient with Noonan syndrome with multiple lentigines and craniosynostosis.
    Rodríguez F; Ponce D; Berward FJ; Lopetegui B; Cassorla F; Aracena M
    Am J Med Genet A; 2019 Aug; 179(8):1598-1602. PubMed ID: 31145547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and cellular evidence for the impact of a hypertrophic cardiomyopathy-associated RAF1 variant on the structure and function of contractile machinery in bioartificial cardiac tissues.
    Nakhaei-Rad S; Haghighi F; Bazgir F; Dahlmann J; Busley AV; Buchholzer M; Kleemann K; Schänzer A; Borchardt A; Hahn A; Kötter S; Schanze D; Anand R; Funk F; Kronenbitter AV; Scheller J; Piekorz RP; Reichert AS; Volleth M; Wolf MJ; Cirstea IC; Gelb BD; Tartaglia M; Schmitt JP; Krüger M; Kutschka I; Cyganek L; Zenker M; Kensah G; Ahmadian MR
    Commun Biol; 2023 Jun; 6(1):657. PubMed ID: 37344639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation.
    Zarate YA; Lichty AW; Champion KJ; Clarkson LK; Holden KR; Matheus MG
    J Child Neurol; 2014 Aug; 29(8):NP13-7. PubMed ID: 23877478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MEK Inhibition in a Newborn with
    Mussa A; Carli D; Giorgio E; Villar AM; Cardaropoli S; Carbonara C; Campagnoli MF; Galletto P; Palumbo M; Olivieri S; Isella C; Andelfinger G; Tartaglia M; Botta G; Brusco A; Medico E; Ferrero GB
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coinheritance of Noonan syndrome and Becker muscular dystrophy.
    Dinopoulos A; Papadopoulou A; Manta P; Kekou K; Kanelopoulos T; Fretzayas A; Kitsiou S
    Neuromuscul Disord; 2010 Jan; 20(1):61-3. PubMed ID: 19875288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
    Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
    Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation.
    Yoshida R; Ogata T; Masawa N; Nagai T
    Pediatr Blood Cancer; 2008 Jun; 50(6):1274-6. PubMed ID: 18253957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation.
    Bessis D; Miquel J; Bourrat E; Chiaverini C; Morice-Picard F; Abadie C; Manna F; Baumann C; Best M; Blanchet P; Bursztejn AC; Capri Y; Coubes C; Giuliano F; Guillaumont S; Hadj-Rabia S; Jacquemont ML; Jeandel C; Lacombe D; Mallet S; Mazereeuw-Hautier J; Molinari N; Pallure V; Pernet C; Philip N; Pinson L; Sarda P; Sigaudy S; Vial Y; Willems M; Geneviève D; Verloes A; Cavé H
    Br J Dermatol; 2019 Jun; 180(6):1438-1448. PubMed ID: 30417923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone and the heart in Noonan syndrome.
    Noordam C
    Horm Res; 2009 Dec; 72 Suppl 2():49-51. PubMed ID: 20029238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.